Observational study on newly diagnosed inflammatory bowel disease patients in Norway

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the outcomes of a protocol-based management approach for patients newly diagnosed with inflammatory bowel disease (IBD) in a specific region of Norway. It is an observational study that aims to collect data on various aspects such as cytokine levels, quality of life, and fatigue assessments to generate hypotheses for future research. The study does not test a specific treatment but rather observes the natural course and management of IBD in the defined population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* newly diagnosed IBD

Exclusion Criteria:

* previous IBD with specific treatment within 10 year
* inability to consent
* inability to adhere to treatment protocol

Where it's running

• Sus
  Stavanger, Norway Recruiting

Study contacts

• Principal investigator: Tore Grimstad, PhD — Helse Stavanger HF
• Study coordinator: tore grimstad
• Email: tore.bjorn.grimstad@sus.no

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease

  This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.

  Recruiting University of Turin, Italy · Turin, Turin · NCT07905859

• Biological Collection to Help Create Models for Digestive Cancers and IBD

  Researchers are gathering tissue and biological samples from patients with inflammatory bowel disease or digestive cancers to build personalized models and test new therapies.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07782203

• Partial enteral nutrition to help IBD patients at nutritional risk maintain weight

  We’re testing whether adding an oral nutritional supplement (LH VIOLA) to standard counseling helps adults with IBD who are at risk of malnutrition keep or gain weight over 16 weeks.

  Recruiting at 4 sites Lionhealth Srl Società Benefit · Rozzano, Milano and 3 other locations · NCT07433946

• Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD

  This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.

  Recruiting University of British Columbia · Vancouver, British Columbia and 1 other locations · NCT07385807

• Pregnancy in people with inflammatory bowel disease

  This project will see if pregnancy changes how often women with IBD have disease flares by analyzing registry data from women who had pregnancies.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT07377188

• Gut bacteria and immune-cell energy in people with IBD and healthy adults

  We will test whether gut bacteria change how immune cells use energy in people with Crohn's disease or ulcerative colitis and in healthy adults by using a short antibiotic course and a labeled fiber.

  Recruiting Phase 2 Assistance Publique - Hôpitaux de Paris · Paris · NCT07300553

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.